{"id":320076,"date":"2025-08-05T14:54:14","date_gmt":"2025-08-05T14:54:14","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/320076\/"},"modified":"2025-08-05T14:54:14","modified_gmt":"2025-08-05T14:54:14","slug":"animal-genetics-market-size-on-track-for-usd-12-11-billion-valuation-by-2034","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/320076\/","title":{"rendered":"Animal Genetics Market Size on Track for USD 12.11 Billion Valuation by 2034"},"content":{"rendered":"

According to Towards Healthcare research, the
\nglobal animal
\ngenetics market size<\/b><\/a> is valued at USD 6.51 billion in 2024 and is
\nexpected to grow to USD 6.93 billion by 2025. The market is projected to reach
\napproximately USD 12.11 billion by 2034, expanding at a compound annual growth
\nrate (CAGR) of 6.4% from 2025 to 2034.<\/p>\n

<\/p>\n

The Complete Study is Now Available for
\nImmediate Access | Download the Sample Pages of this Report @ <\/b>https:\/\/www.towardshealthcare.com\/download-sample\/5446<\/b><\/a><\/p>\n

Wide-range influencing factors on the
\nanimal genetics market expansion, including a rise in demand for animal-derived
\nprotein, like meat, milk, and eggs, breakthroughs in genetic technologies, and
\nthe growing awareness about animal health. Moreover, enhanced focus on superior
\nbreeds and the growth of companion animal ownership are also fueling the
\noverall market development. <\/p>\n

The<\/b> Animal
\nGenetics Market: Highlights <\/b><\/p>\n

\u2022
\n\u00a0North America held a dominating
\nrevenue share by 32% of the market in 2024.<\/p>\n

\u2022
\n\u00a0Asia-Pacific is expected to be
\nthe fastest-growing region in the upcoming years.<\/p>\n

\u2022
\n\u00a0By animal type, the cattle
\nsegment led the market in 2024.<\/p>\n

\u2022
\n\u00a0By animal type, the companion segment
\nis expected to register rapid expansion during 2025-2034.<\/p>\n

\u2022
\n\u00a0By type, the assistive
\nreproductive technologies segment dominated the animal genetics market in 2024.<\/p>\n

\u2022
\n\u00a0By type, the genomic\/genetic
\nsegment is expected to grow fastest in the predicted timeframe.<\/p>\n

\u2022
\n\u00a0By distribution channel, the
\nprivate segment was dominant in the market in 2024 and is expected to show the
\nfastest growth during 2025-2034.<\/p>\n

Market Overview <\/b><\/p>\n

Primarily, animal genetics is the study of
\nheredity and diversity in animals, aiming at trait analysis and assessment of
\ngenetic variances which are impacting overall animal characteristics.
\nCurrently, the animal genetics market is propelled by accelerating demand for
\nanimal protein, major technological advances, and the need for sustainable
\nlivestock production.\u00a0Furthermore, this market contributes to major
\ndevelopments in the application of CRISPR-Cas9 for gene editing to improve
\ntraits like disease resistance and growth, the progress of genetic testing
\nservices, and the development of tailored breeding techniques.\u00a0<\/p>\n

Key Metrics and Overview<\/b><\/p>\n\n\n

Metric<\/b><\/p>\n<\/td>\n\n

Details<\/b><\/p>\n<\/td>\n<\/tr>\n\n\n

Market Size in 2024<\/p>\n<\/td>\n\n

USD 6.51 Billion<\/p>\n<\/td>\n<\/tr>\n\n\n

Projected Market Size in 2034<\/p>\n<\/td>\n\n

USD 12.11 Billion<\/p>\n<\/td>\n<\/tr>\n\n\n

CAGR (2025 – 2034)<\/p>\n<\/td>\n\n

6.4%<\/p>\n<\/td>\n<\/tr>\n\n\n

Leading Region<\/p>\n<\/td>\n\n

North America by 32%<\/p>\n<\/td>\n<\/tr>\n\n\n

Market Segmentation<\/p>\n<\/td>\n\n

By Animal Type, By Type, By Distribution Channel, By Region<\/p>\n<\/td>\n<\/tr>\n\n\n

Top Key Players<\/p>\n<\/td>\n\n

Neogen Corporation, EW Group, Envigo, Genus, Norsvin USA, LLC, CRV
\n Holding B.V., Animal Genetics Inc, Semex, Zoetis, Genus plc, URUS Group LP,
\n STgenetics<\/p>\n<\/td>\n<\/tr>\n

\u00a0<\/p>\n

You can place an order or ask any
\nquestions, please feel free to contact us at <\/b>sales@towardshealthcare.com<\/b><\/a><\/p>\n

Widespread Technological Breakthroughs:
\nMajor Potential <\/b><\/p>\n

In the animal genetics market, several
\ninnovative technological adoptions are boosting the overall market expansion,
\nincluding the emergence of genetic selection in the analysis of an animal’s DNA
\nto estimate its genetic merit for various traits. As well as the application of
\nnovel gene
\nediting techniques<\/b><\/a>, like CRISPR\/Cas9, TALEN, and ZFN, are accurately
\naltering an animal’s genes to incorporate desired traits or discard undesirable
\nones. Moreover, Artificial Insemination (AI) and Embryo Transfer (ET) are
\nemployed to disseminate superior genetics more efficiently.\u00a0<\/p>\n

Ethical Concerns and Consumer
\nPreferences: Major Restraint<\/b><\/p>\n

Globally, the animal genetics market is
\nfacing a few challenges, such as increasing ethical concerns about animal
\nwelfare, biodiversity, and potential ecological impacts. Also, the public’s
\nseeking and acceptance of genetically modified animals and relevant products
\nare impacted by these concerns. Moreover, rising demand for higher-quality
\nproducts and choices, like lab-grown meat, is creating a major hurdle for this
\nmarket development.<\/p>\n

The<\/b> Animal
\nGenetics Market: Regional Analysis<\/b><\/p>\n

<\/b><\/p>\n

In 2024, North America dominated the global
\nmarket due to the presence of a well-developed livestock industry, coupled with
\nadvanced agricultural practices. Additionally, accelerating consumption of
\nmeat, dairy, and eggs in this region drives the demand for enhanced animal
\ngenetics to boost productivity and efficacy. Besides this, broad adoption of
\nsophisticated technologies, particularly artificial insemination, embryo
\ntransfer, and genetic screening, is assisting in better animal health,
\nproductivity, and overall performance.\u00a0<\/p>\n

Whereas, the US is experiencing major
\ngrowth, with increased investments in research and development in animal
\ngenetics, with the emergence of artificial insemination, embryo transfer
\ntechniques. Also, the US government is encouraging with their favourable
\npolicies, research funding, and collaborations between academic institutions
\nand industry players are fostering the novel advancements in the animal
\ngenetics market.<\/p>\n

And, another region in North America is
\nCanada, also facing crucial expansion, as of step towards the development of
\nsustainable and environmentally friendly farming practices.\u00a0As well as an
\nexpanded focus on optimizing feed efficiency, minimizing greenhouse gas
\nemissions from livestock, and encouraging animal health and welfare.\u00a0<\/p>\n

The Asia Pacific is Predicted to Grow at
\na Rapid CAGR During 2025-2034<\/b><\/p>\n

In the future, the Asia Pacific will expand
\nrapidly, with growing demand for animal-derived protein, comprising meat,
\ndairy, and eggs.\u00a0Besides this, accelerating awareness about the advantages
\nof advanced genetic technologies to expand animal health, outcomes, and
\nprofitability among farmers and livestock producers. Furthermore, emphasis on
\ndisease management by utilizing genetic testing and breeding programs to detect
\nand remove genetic diseases in livestock is propelling this region\u2019s animal
\ngenetics market.<\/p>\n

In ASAP, India is putting major pressure on
\nanimal-derived food products, as well as the Indian government providing funds
\nfor R&D in animal genetics, which are driving the overall market expansion.
\nAlong with this, “Rashtriya Gokul Mission” in India focuses on
\nimproving the productivity and milk production of bovines through genetic
\nupgrades.\u00a0<\/p>\n

For instance,<\/p>\n

\u2022\u00a0 In August
\n2024, Allozymes, a global innovator in enzyme discovery and engineering, made a
\nstrategic partnership with Adisseo, one of the world’s major animal nutrition
\ncompanies, to evolve novel bioprocesses for animal feed ingredient production.<\/p>\n

However, in China, significant innovations
\nin genomic sequencing, gene
\nediting like CRISPR<\/b><\/a>, and bioinformatics
\nare revolutionizing breeding programs<\/b><\/a> in the animal genetics market.
\nThese technologies allow more precise and targeted genetic alterations to boost
\ntraits like growth rate, feed efficiency, and disease resistance.\u00a0<\/p>\n

Get the latest insights on life science
\nindustry segmentation with our Annual Membership: <\/b>https:\/\/www.towardshealthcare.com\/get-an-annual-membership<\/b><\/a><\/p>\n

The<\/b> Animal
\nGenetics Market: Segmentation Analysis<\/b><\/p>\n

By animal type analysis<\/b><\/p>\n

The cattle segment held the biggest revenue
\nshare of the market in 2024. Around the world, rising cases of genetic
\ndisorders in cattle are primarily contributing to the demand for genetic
\ntesting and breeding programs focused on preventing these concerns.\u00a0Besides
\nthis, the enormous demand for animal-driven protein food is fueling demand for
\nhighly effective and productive cattle breeds.\u00a0However, sensor-based
\nmonitoring and AI technologies are accelerating genetic selection processes in
\ncattle, which enables robust monitoring of livestock health and productivity.<\/p>\n

However, the companion segment is estimated
\nto grow fastest during the forecast period in the animal genetics market. The
\nsegment is driven by a major emphasis on ensuring the health and well-being of
\ntheir companion animals among pet owners. This mainly consists of genetic
\ntesting and other advanced services to determine and mitigate possible genetic
\nconditions. The “humanization” of pets is a crucial trend, resulting
\nin escalated expenditure on pet care, especially genetic testing and other
\nadvanced services.\u00a0<\/p>\n

By type analysis<\/b><\/p>\n

In 2024, the assistive reproductive
\ntechnologies segment was dominant in the animal genetics market. Primarily, the
\nneed for robust and sustainable livestock production leads to increased
\nadoption of ART.\u00a0Moreover, innovations in artificial insemination, embryo
\ntransfer, in-vitro fertilization, and genome editing are fostering breeding
\nyield and promoting the broad adoption of these technologies.\u00a0<\/p>\n

Although the genomic\/genetic segment is
\nanticipated to register a rapid expansion during 2025-2034, to fulfill a vital
\npressure for animal-derived protein food products, innovative
\nand advanced DNA sequencing<\/b><\/a>, bioinformatics, and gene editing
\ntechnologies are widely used. Additionally, the segment encompasses tools, such
\nas CRISPR, enabling targeted changes of animal genes, providing the
\npossibilities to expand traits like disease resistance, growth rate, and milk
\nproduction. Other technologies, mainly artificial insemination and embryo
\ntransfer, are more sophisticated, allowing for the effective dissemination of
\ndesirable genetic traits.\u00a0<\/p>\n

By distribution channel analysis<\/b><\/p>\n

During 2024, the private segment dominated
\nthe animal genetics market and will expand fastest in the studied years.
\nPrivate distributors are more agile and flexible, enabling them to develop
\ntailored solutions to satisfy certain customer needs and market
\ndemands.\u00a0Also, many private companies are heavily investing in R&D to
\ndevelop more sophisticated genetic solutions, including DNA sequencing, disease
\ndiagnostics, and tailored breeding programs.\u00a0Additionally, the
\ncollaboration among public and private sectors, like the joint venture between
\nGenetics Australia Cooperative and URUS Group LP, is assisting in the market
\nreach and propelling innovation.\u00a0<\/p>\n

Top Companies and Their Contributions to
\nthe Animal Genetics Market<\/b><\/p>\n\n\n

Company<\/b><\/p>\n<\/td>\n\n

Contributions and Offerings<\/b><\/p>\n<\/td>\n<\/tr>\n\n\n

Neogen Corporation<\/b><\/p>\n<\/td>\n\n

Provides advanced genetic testing and diagnostic solutions to
\n enhance animal health, breeding, and food safety. Offers genomics tools to
\n improve livestock productivity and disease resistance.<\/p>\n<\/td>\n<\/tr>\n\n\n

EW Group<\/b><\/p>\n<\/td>\n\n

A global leader in poultry genetics, EW Group delivers high-performance
\n breeding stock and innovative genetic solutions to improve efficiency, animal
\n welfare, and sustainability in poultry production.<\/p>\n<\/td>\n<\/tr>\n\n\n

Envigo<\/b><\/p>\n<\/td>\n\n

Specializes in animal research models and genetics, supporting
\n pharmaceutical and biotech companies with genetically characterized animals
\n for research and development.<\/p>\n<\/td>\n<\/tr>\n\n\n

Genus<\/b><\/p>\n<\/td>\n\n

A leading animal genetics company focusing on cattle and pigs,
\n Genus develops superior breeding stock through cutting-edge genomic
\n technologies to enhance yield, health, and sustainability.<\/p>\n<\/td>\n<\/tr>\n\n\n

Norsvin USA, LLC<\/b><\/p>\n<\/td>\n\n

Focuses on swine genetics, providing high-quality breeding stock
\n and genetic services aimed at improving reproductive performance, growth
\n rates, and meat quality.<\/p>\n<\/td>\n<\/tr>\n\n\n

CRV Holding B.V.<\/b><\/p>\n<\/td>\n\n

Offers dairy cattle genetics globally, enhancing milk production,
\n fertility, and disease resistance through advanced genomic selection and
\n breeding programs.<\/p>\n<\/td>\n<\/tr>\n\n\n

Animal Genetics Inc<\/b><\/p>\n<\/td>\n\n

Delivers comprehensive genetic testing and analysis services for
\n livestock, enabling producers to make informed breeding decisions to optimize
\n traits such as growth and health.<\/p>\n<\/td>\n<\/tr>\n\n\n

Semex<\/b><\/p>\n<\/td>\n\n

Provides dairy genetics and reproductive technologies worldwide,
\n leveraging genomics to improve milk yield, animal health, and longevity in
\n dairy herds.<\/p>\n<\/td>\n<\/tr>\n\n\n

Zoetis<\/b><\/p>\n<\/td>\n\n

Primarily a veterinary pharmaceutical company, Zoetis also offers
\n genetic testing and diagnostics to support animal health and improve breeding
\n outcomes across species.<\/p>\n<\/td>\n<\/tr>\n\n\n

Genus plc<\/b><\/p>\n<\/td>\n\n

Focuses on global animal genetics, particularly in cattle and
\n pigs, using genomic tools and breeding expertise to improve production
\n efficiency, animal health, and sustainability.<\/p>\n<\/td>\n<\/tr>\n

\u00a0<\/b><\/p>\n

Elevate your healthcare strategy with
\nTowards Healthcare. Enhance efficiency and drive better outcomes schedule a
\ncall today: <\/b>https:\/\/www.towardshealthcare.com\/schedule-meeting<\/b><\/a><\/p>\n

Browse More Insights of Towards
\nHealthcare<\/b><\/a>:<\/b><\/p>\n

The global animal
\nbiotechnology market<\/b><\/a> is experiencing strong growth, rising from $28.17
\nbillion in 2024 to $30.97 billion in 2025, and is expected to reach
\napproximately $72.6 billion by 2034. This growth reflects a solid CAGR of 9.93%
\nover the forecast period.<\/p>\n

The companion
\nanimal health market<\/b><\/a> is also on a steady upward path, expanding from
\n$25.28 billion in 2024 to $27.64 billion in 2025, and projected to hit around
\n$61.74 billion by 2034, growing at a CAGR of 9.34%.<\/p>\n

The veterinary
\nmonoclonal antibodies market<\/b><\/a> is gaining rapid traction, growing from
\n$1.23 billion in 2024 to $1.45 billion in 2025, and expected to soar to about
\n$6 billion by 2034, driven by a robust CAGR of 17.13%.<\/p>\n

The animal
\nmodel market<\/b><\/a> continues to expand, increasing from $2.54 billion in 2024
\nto $2.76 billion in 2025, and forecasted to reach nearly $5.81 billion by 2034,
\nwith a steady CAGR of 8.64%.<\/p>\n

The animal
\nvaccine market<\/b><\/a> is projected to grow significantly, rising from $18.98
\nbillion in 2025 to about $44.77 billion by 2034, supported by a healthy CAGR of
\n10% throughout the forecast period.<\/p>\n

The epigenetic
\nantibodies market<\/b><\/a> is set for impressive growth, moving from $2.29
\nbillion in 2024 to $2.7 billion in 2025, and expected to reach around $12.01
\nbillion by 2034, expanding at a CAGR of 18.04%.<\/p>\n

The direct-to-consumer
\ngenetic testing market<\/b><\/a> is booming, rising from $2.45 billion in 2024 to
\n$3.05 billion in 2025, with projections showing it could reach approximately
\n$21.85 billion by 2034, thanks to a rapid CAGR of 24.44%<\/p>\n

The genetic
\nmaterial market<\/b><\/a> is also poised for substantial growth over the next
\ndecade, driven by advances in gene therapies, precision medicine, and biopharma
\nresearch.<\/p>\n

Meanwhile, the CRISPR
\ntechnology market<\/b><\/a> is accelerating, growing from $5.72 billion in 2024
\nto $6.67 billion in 2025, and forecasted to climb to $26.22 billion by 2034,
\nreflecting a CAGR of 16.54%.<\/p>\n

The molecular
\ncytogenetics market<\/b><\/a> is on an upward trend, increasing from $2.51
\nbillion in 2024 to $2.78 billion in 2025, and expected to reach $6.9 billion by
\n2034, with a CAGR of 10.64%.<\/p>\n

Animal Genetics Market Companies<\/b><\/p>\n

<\/b><\/p>\n

\u2022\u00a0 Neogen Corporation<\/p>\n

\u2022\u00a0 EW Group<\/p>\n

\u2022\u00a0 Envigo<\/p>\n

\u2022\u00a0 Genus<\/p>\n

\u2022\u00a0 Norsvin USA, LLC<\/p>\n

\u2022\u00a0 CRV Holding B.V.<\/p>\n

\u2022\u00a0 Animal Genetics Inc<\/p>\n

\u2022\u00a0 Semex<\/p>\n

\u2022\u00a0 Zoetis<\/p>\n

\u2022\u00a0 Genus plc<\/p>\n

\u2022\u00a0 URUS Group LP<\/p>\n

\u2022\u00a0 STgenetics<\/p>\n

Top Companies Latest Updates<\/b><\/p>\n\n\n

Company <\/p>\n<\/td>\n\n

Recent Developments <\/p>\n<\/td>\n<\/tr>\n\n\n

Neogen Corporation (January 2025)<\/p>\n<\/td>\n\n

Launched Igenity\u00ae BCHF to support the industry in mitigating
\n bovine congestive heart failure risk<\/p>\n<\/td>\n<\/tr>\n\n\n

Zoetis (August 2024)<\/p>\n<\/td>\n\n

Expanded their capability center in Hyderabad <\/p>\n<\/td>\n<\/tr>\n\n\n

URUS Group LP (June 2024)<\/p>\n<\/td>\n\n

Made a partnership agreement with CVC Capital Partners IX (\u201cCVC\u201d)
\n to invest in URUS Group<\/p>\n<\/td>\n<\/tr>\n

\u00a0<\/p>\n

What are the Major Drifts in the<\/b> Animal Genetics Market?<\/b><\/p>\n

\u27a2 In June 2025, the Federal Government launched the National Strategy
\nand Action Plan (NSAP) on Animal Genetic Resources (AnGR) management to confirm
\neffective conservation, application, and development of Nigeria\u2019s livestock
\nsector.<\/p>\n

\u27a2 In March 2025, Telangana is set to accelerate its livestock
\nbreeding and fisheries industries with significant investments of Rs. 21.06 Cr
\nin new facilities, to enhance the breeding of high-quality dairy cattle around
\nthe state. <\/p>\n

\u27a2 In October 2024, Sahel Capital, an investor in the food and
\nagriculture sector in sub-Saharan Africa approved a $500,000 CAPEX loan from
\nits Social Enterprise Fund for Agriculture in Africa (SEFAA) facility to
\nGeneplus, a Kenyan-based company specialising in livestock genetics, providing
\ndairy farmers with sexed and unsexed cattle semen to support enhancement in
\nherd productivity and boost milk yields.<\/p>\n

\u27a2 In October 2024, Prime Minister Narendra Modi introduced the
\nUnified Genomic Chip, called \u2018Gau Chip\u2019, and indigenous sex-sorted semen
\nproduction technology in Maharashtra to support farmers in detecting
\nhigh-quality cattle and producing more female calves at affordable expenses. <\/p>\n

Animal Genetics Market Segmentation<\/b><\/p>\n

By Animal Type<\/b><\/p>\n

\u2022\u00a0 Cattle<\/p>\n

\u2022\u00a0 Pigs<\/p>\n

\u2022 \u00a0Sheep & Goats<\/p>\n

\u2022\u00a0 Companion Animals<\/p>\n

\u2022\u00a0 Others<\/p>\n

By Type<\/b><\/p>\n

\u2022\u00a0 Assistive Reproduction Technologies<\/p>\n

\u2022\u00a0 Live Animals<\/p>\n

\u2022\u00a0 Genomic\/ Genetic Testing<\/p>\n

By Distribution Channel<\/b><\/p>\n

\u2022\u00a0 Private<\/p>\n

\u2022\u00a0 Public<\/p>\n

By Region<\/b><\/p>\n

\u2022\u00a0 North America<\/p>\n

\u2022\u00a0 Asia Pacific<\/p>\n

\u2022\u00a0 Europe<\/p>\n

\u2022\u00a0 Latin America<\/p>\n

\u2022\u00a0 Middle East and Africa (MEA)<\/p>\n

Immediate Delivery Available | Buy
\nThis Premium Research @\u00a0<\/b><\/a>https:\/\/www.towardshealthcare.com\/price\/5446<\/b><\/a><\/p>\n

You can place an order or ask any
\nquestions, please feel free to contact us at <\/b>sales@towardshealthcare.com<\/b><\/a><\/p>\n

About Us<\/b><\/p>\n

Towards Healthcare<\/b> is a leading global provider of technological solutions, clinical
\nresearch services, and advanced analytics, with a strong
\nemphasis on life science research<\/b><\/a>. Dedicated to
\nadvancing innovation in the life sciences sector, we build strategic partnerships
\nthat generate actionable insights and transformative breakthroughs. As a global
\nstrategy consulting firm, we empower life science leaders to gain a competitive
\nedge, drive research excellence, and accelerate sustainable growth.<\/p>\n

You can place an order or ask any
\nquestions, please feel free to contact us at <\/b>sales@towardshealthcare.com<\/b><\/a><\/p>\n

Europe Region – +44 778 256 0738<\/b><\/p>\n

North America Region – +1 8044 4193 44<\/b><\/p>\n

Web:\u00a0<\/b>https:\/\/www.towardshealthcare.com<\/b><\/a><\/p>\n

Find us on social platforms: <\/b>LinkedIn<\/b><\/a> | <\/b>Twitter<\/b><\/a> | <\/b>Instagram<\/b><\/a><\/p>\n

\u00a0<\/p>\n

\u00a0<\/b><\/p>\n